Psychiatry Investig > Volume 21(11); 2024 > Article |
|
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Conflicts of Interest
C. Hyung Keun Park and Seockhoon Chung, a contributing editors of the Psychiatry Investigation, were not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.
Author Contributions
Conceptualization: all authors. Data curation: C. Hyung Keun Park, Seockhoon Chung. Formal analysis: Seockhoon Chung. Investigation: Seockhoon Chung. Methodology: C. Hyung Keun Park, Seong Yoon Kim. Writing—original draft: all authors. Writing—review & editing: all authors.
Funding Statement
None
Values are presented as number (%) or mean±standard deviation. COVID-19, coronavirus disease-2019; PHQ-9, Patient Health Questionnaire-9 items; SAVE-3, Stress and Anxiety to Viral Epidemics-3 items; ISI, Insomnia Severity Index; INQ, Interpersonal Needs Questionnaire; TB, thwarted belongingness; PB, perceived burdensomeness; CD-RISC2, Connor-Davidson Resilience Scale-2 items
Variables | Years of employment | PHQ-9 | SAVE-3 | ISI | INQ-TB | INQ-PB |
---|---|---|---|---|---|---|
PHQ-9 | -0.01 | |||||
SAVE-3 | -0.05 | 0.31** | ||||
ISI | -0.02 | 0.56** | 0.26** | |||
INQ-TB | -0.05 | 0.49** | 0.17** | 0.28** | ||
INQ-PB | 0.08 | 0.47** | 0.24** | 0.24** | 0.41** | |
CD-RISC2 | 0.03 | -0.39** | -0.17** | -0.25** | -0.33** | -0.39** |
Variables | β | p | Adjusted R2 | F, p |
---|---|---|---|---|
PHQ-9 | 0.49 | F=53.03, p<0.001** | ||
Years of employment | 0.003 | 0.942 | ||
SAVE-3 | 0.11 | 0.012* | ||
ISI | 0.39 | <0.001** | ||
INQ-TB | 0.24 | <0.001** | ||
INQ-PB | 0.20 | <0.001** | ||
CD-RISC2 | -0.12 | <0.001** |
COVID-19, coronavirus disease-2019; PHQ-9, Patient Health Questionnaire-9 items; SAVE-3, Stress and Anxiety to Viral Epidemics-3 items; ISI, Insomnia Severity Index; INQ, Interpersonal Needs Questionnaire; TB, thwarted belongingness; PB, perceived burdensomeness; CD-RISC2, Connor-Davidson Resilience Scale-2 items
Effect | Standardized estimator | S.E. | Z | p | 95% CI |
---|---|---|---|---|---|
Direct effect | |||||
SAVE-3 → PHQ-9 | 0.11 | 0.04 | 2.59 | 0.010* | 0.03 to 0.19 |
Indirect effect | |||||
SAVE-3 → ISI → PHQ-9 | 0.10 | 0.02 | 4.23 | <0.001** | 0.05 to 0.14 |
SAVE-3 → INQ-TB → PHQ-9 | 0.04 | 0.02 | 2.72 | 0.006** | 0.01 to 0.07 |
SAVE-3 → INQ-PB → PHQ-9 | 0.05 | 0.02 | 3.13 | 0.002** | 0.02 to 0.08 |
SAVE-3 → CD-RISC 2 → PHQ-9 | 0.02 | 0.01 | 2.04 | 0.041* | 0.0001 to 0.04 |
Path coefficients | |||||
SAVE-3 → ISI | 0.26 | 0.05 | 4.77 | <0.001** | 0.15 to 0.36 |
ISI → PHQ-9 | 0.39 | 0.04 | 9.20 | <0.001** | 0.30 to 0.47 |
SAVE-3 → INQ-TB | 0.17 | 0.06 | 3.16 | 0.002** | 0.07 to 0.28 |
INQ-TB → PHQ-9 | 0.24 | 0.04 | 5.36 | <0.001** | 0.15 to 0.33 |
SAVE-3 → INQ-PB | 0.24 | 0.05 | 4.41 | <0.001** | 0.13 to 0.34 |
INQ-PB → PHQ-9 | 0.20 | 0.05 | 4.43 | <0.001** | 0.11 to 0.29 |
SAVE-3 → CD-RISC 2 | -0.17 | 0.05 | -3.10 | 0.002** | -0.28 to -0.06 |
CD-RISC 2 → PHQ-9 | -0.12 | 0.04 | -2.72 | 0.007** | -0.20 to -0.03 |
Total effect | |||||
SAVE-3 → PHQ-9 | 0.21 | 0.04 | 5.53 | <0.001** | 0.13 to 0.28 |
S.E., standard error; CI, confidence interval; SAVE-3, Stress and Anxiety to Viral Epidemics-3 items; PHQ-9, Patient Health Questionnaire-9 items; ISI, Insomnia Severity Index; INQ, Interpersonal Needs Questionnaire; TB, thwarted belongingness; PB, perceived burdensomeness; CD-RISC 2, Connor-Davidson Resilience Scale-2 items